Form 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Act of 1934

Date of Report (Date of earliest event reported): November 18, 2003


                          MERIDIAN BIOSCIENCE, INC.                           
(Exact name of Registrant as specified in its Charter)


                      Ohio                                          0-14902                              31-0888197        
(State or Other Jurisdiction of
         Incorporation) 		(Commission File Number)  (IRS Employer
Identification No.)


3471 River Hills Drive, Cincinnati, Ohio    45244   
(Address of Principal Executive Offices) (Zip Code)


Registrant's telephone number, including area code (513) 271-3700


                                                                                                             
(Former name or former address, if changed since last report.)

Item 12 – Results of Operations and Financial Condition.

        On November 18, 2003, the Registrant issued a press release announcing its financial results for the year ended September 30, 2003. A copy of the press release is furnished as Exhibit 99 to this report and is incorporated herein by reference.

SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.





Date:  November 19, 2003		 MERIDIAN BIOSCIENCE, INC.


BY: /s/ Melissa Lueke
——————————————
Melissa Lueke
Vice President and Chief Financial Officer
(Principal Accounting Officer)

FORM 8-K

INDEX TO EXHIBITS

Index
Number
 Exhibit Description
99               Press release dated November 18, 2003.